IMTX
Price
$5.43
Change
-$0.16 (-2.86%)
Updated
Jun 27 closing price
Capitalization
660.02M
43 days until earnings call
IMVT
Price
$16.39
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
2.75B
37 days until earnings call
Interact to see
Advertisement

IMTX vs IMVT

Header iconIMTX vs IMVT Comparison
Open Charts IMTX vs IMVTBanner chart's image
Immatics
Price$5.43
Change-$0.16 (-2.86%)
Volume$563.3K
Capitalization660.02M
Immunovant
Price$16.39
Change-$0.00 (-0.00%)
Volume$728
Capitalization2.75B
IMTX vs IMVT Comparison Chart in %
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. IMVT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and IMVT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IMTX: $5.43 vs. IMVT: $16.10)
Brand notoriety: IMTX and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 81% vs. IMVT: 217%
Market capitalization -- IMTX: $660.02M vs. IMVT: $2.75B
IMTX [@Biotechnology] is valued at $660.02M. IMVT’s [@Biotechnology] market capitalization is $2.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 4 TA indicator(s) are bullish while IMVT’s TA Score has 6 bullish TA indicator(s).

  • IMTX’s TA Score: 4 bullish, 4 bearish.
  • IMVT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а -3.12% price change this week, while IMVT (@Biotechnology) price change was +1.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IMTX is expected to report earnings on Aug 12, 2025.

IMVT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.75B) has a higher market cap than IMTX($660M). IMTX YTD gains are higher at: -23.629 vs. IMVT (-35.002). IMTX has higher annual earnings (EBITDA): -4.49M vs. IMVT (-437.78M). IMVT has more cash in the bank: 714M vs. IMTX (544M). IMVT has less debt than IMTX: IMVT (98K) vs IMTX (18.4M). IMTX has higher revenues than IMVT: IMTX (144M) vs IMVT (0).
IMTXIMVTIMTX / IMVT
Capitalization660M2.75B24%
EBITDA-4.49M-437.78M1%
Gain YTD-23.629-35.00268%
P/E Ratio29.35N/A-
Revenue144M0-
Total Cash544M714M76%
Total Debt18.4M98K18,776%
FUNDAMENTALS RATINGS
IMTX vs IMVT: Fundamental Ratings
IMTX
IMVT
OUTLOOK RATING
1..100
8663
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9097
PRICE GROWTH RATING
1..100
6163
P/E GROWTH RATING
1..100
60100
SEASONALITY SCORE
1..100
5027

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (43) in the null industry is in the same range as IMTX (63). This means that IMVT’s stock grew similarly to IMTX’s over the last 12 months.

IMVT's Profit vs Risk Rating (100) in the null industry is in the same range as IMTX (100). This means that IMVT’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (90) in the null industry is in the same range as IMVT (97). This means that IMTX’s stock grew similarly to IMVT’s over the last 12 months.

IMTX's Price Growth Rating (61) in the null industry is in the same range as IMVT (63). This means that IMTX’s stock grew similarly to IMVT’s over the last 12 months.

IMTX's P/E Growth Rating (60) in the null industry is somewhat better than the same rating for IMVT (100). This means that IMTX’s stock grew somewhat faster than IMVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXIMVT
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTWRX18.440.25
+1.37%
Templeton World R6
MXXVX36.550.39
+1.08%
Matthew 25
OAZMX160.481.14
+0.72%
Oakmark R6
SQCBX13.420.02
+0.15%
X-Square Balanced Fund, LLC C
DVIPX19.230.02
+0.10%
Davenport Value & Income

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with CGON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-2.86%
CGON - IMTX
47%
Loosely correlated
-0.46%
CRNX - IMTX
47%
Loosely correlated
-0.10%
RGNX - IMTX
47%
Loosely correlated
-4.11%
OCUL - IMTX
47%
Loosely correlated
-2.54%
IMVT - IMTX
47%
Loosely correlated
-1.77%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-1.77%
ROIV - IMVT
62%
Loosely correlated
-1.81%
OCUL - IMVT
55%
Loosely correlated
-2.54%
CGON - IMVT
54%
Loosely correlated
-0.46%
IDYA - IMVT
52%
Loosely correlated
-4.13%
DNLI - IMVT
52%
Loosely correlated
-2.69%
More